Episode 18: Data’s Influence on the Pharma C-suite
Michelle and Christen sit down with one of this year's Emerging Pharma Leaders, Christopher Boone, the head of real-world data and analytics center of excellence at Pfizer. We discuss what peaked Boone's interest in public health and data; the progression of how pharma and data have merged; what challenges pharma faces with data and what lies ahead; and where he got his infamous twitter handle.Pharm Exec’s Editor-in-Chief Lisa Henderson and European Editor Julian Upton join Christen Harm and Michelle Maskaly to talk about the topic of specialty pharma, which was featured in the magazine’s September issue. They discuss the marketing, logistics, pricing, and other challenges executives in the specialty pharma industry face, as well as dive into the forces that are driving this segment of the industry and what the future will look like.
Michelle and Christen sit down with one of this year's Emerging Pharma Leaders, Christopher Boone, the head of real-world data and analytics center of excellence at Pfizer. We discuss what peaked Boone's interest in public health and data; the progression of how pharma and data have merged; what challenges pharma faces with data and what lies ahead; and where he got his infamous twitter handle.
You can listen and/or download the episode on SoundCloud, or directly through iTunes, GooglePlay, Stitcher, and Overcast.
The Misinformation Maze: Navigating Public Health in the Digital Age
March 11th 2025Jennifer Butler, chief commercial officer of Pleio, discusses misinformation's threat to public health, where patients are turning for trustworthy health information, the industry's pivot to peer-to-patient strategies to educate patients, and more.
